Literature DB >> 10729843

Implantable atrial defibrillator and detection of atrial flutter.

M Schwartz1, C Maglio, M Akhtar, J Sra.   

Abstract

The implantable atrial defibrillator (IAD) is designed to detect and treat atrial fibrillation (AF) with low energy synchronized shocks. A patient with a history of persistent AF was implanted with an IAD after ineffective treatment with procainamide and sotalol. Through four months of follow-up, the IAD performed appropriate detection and treatment of AF. During the fifth month, the patient was put on flecainide in an attempt to minimize the AF recurrence rate. On flecainide the patient experienced typical atrial flutter which required IAD reprogramming for appropriate detection and therapy delivery. This case report examines the optimization of the IAD to detect atrial flutter. Six months of follow-up after optimization the IAD has shown appropriate detection of both atrial flutter and AF. During the entire follow-up period the IAD had appropriate detection of sinus rhythm (no false positive detection, i.e. sinus rhythm as AF).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10729843     DOI: 10.1023/a:1009825931490

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  5 in total

1.  Hybrid pharmacologic and ablative therapy: a novel and effective approach for the management of atrial fibrillation.

Authors:  D T Huang; K M Monahan; P Zimetbaum; P Papageorgiou; L M Epstein; M E Josephson
Journal:  J Cardiovasc Electrophysiol       Date:  1998-05

2.  Feasibility of atrial fibrillation detection and use of a preceding synchronization interval as a criterion for shock delivery in humans with atrial fibrillation.

Authors:  J S Sra; C Maglio; A Dhala; Z Blanck; M Biehl; S Deshpande; E T Keelan; M R Jazayeri; M Akhtar
Journal:  J Am Coll Cardiol       Date:  1996-11-15       Impact factor: 24.094

3.  Detection of atrial fibrillation during sinus tachycardia induced by exercise in patients with implantable atrial defibrillators.

Authors:  H F Tse; C P Lau; G M Ayers
Journal:  Pacing Clin Electrophysiol       Date:  1999-01       Impact factor: 1.976

4.  Electrical proarrhythmia: induction of inappropriate atrial therapies due to far-field R wave oversensing in a new dual chamber defibrillator.

Authors:  C Wolpert; W Jung; C Scholl; S Spehl; J Cyran; B Lüderitz
Journal:  J Cardiovasc Electrophysiol       Date:  1998-08

5.  Atrioverter: an implantable device for the treatment of atrial fibrillation.

Authors:  H J Wellens; C P Lau; B Lüderitz; M Akhtar; A L Waldo; A J Camm; C Timmermans; H F Tse; W Jung; L Jordaens; G Ayers
Journal:  Circulation       Date:  1998-10-20       Impact factor: 29.690

  5 in total
  2 in total

1.  Vigilance and the technologic promise of the third millennium.

Authors:  S Saksena
Journal:  J Interv Card Electrophysiol       Date:  2000-04       Impact factor: 1.900

2.  Atrial defibrillation at the millennium: new challenges for evolving technology.

Authors:  R Boccadamo
Journal:  J Interv Card Electrophysiol       Date:  2000-04       Impact factor: 1.900

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.